Function Study on Microbial Secondary Metabolites
Principal Investigator: Xuejun Jiang
Brief introduction of the principal investigator:
Xuejun Jiang, M. D., Ph. D., Professor, Doctoral Supervisor. He graduated from Health Science Center of Peking University and got doctor’s degree in 1998. At present, he is the professor of State Key Laboratory of Mycology (Prepared), Institute of Microbiology, Chinese Academy of Sciences.
Work experience of the principal investigator:
2009.12-present State Key Laboratory of Mycology (Prepared), Institute of Microbiology, Chinese Academy of Sciences, Professor
2005-2006 Visiting Scholar, Health Science Center, University of Colorado, Denver
2003-2009 Associate-Professor, Institute of Microbiology, Chinese Academy of Sciences
2000-2002 Postdoctoral, Health Science Center, University of Colorado, Denver.
1999-2000 Postdoctoral, Medical School of Utah University, Salt City
1998-1999 Postdoctoral, Medical School of Nagoya City University, Nagoya
1989-1992 People’s Hospital of Zhangqiu City, Shandong Province
1983-1988 Worker's Hospital of Iron and Steel Refractory Plant in Jinan, Shandong Province
Education of the principal investigator:
1995-1998 Health Science Center of Peking University, Ph. D.
1992-1995 Medical School of Qingdao University, M.S.
1980-1983 Heze Medical College, Shandong Province
National Key Basic Research Program (973), The Invasion Mechanism of Enveloped Viruses III (2009-2014), Major Science and Technology Project of Ministry of Health ‘The Prevention and Curing of AIDS, Viral Hepatitis and Other Major Infectious Diseases’, The Study on Tuberculosis Immune Mechanism (2008.1-2010.12), National High Technology Research and Development Program (863), The Development of Vaccines for Vaccinia Virus and DNA Epitope Peptide Avian Influenza (2006.12-2010.12), Two General Projects of National Natural Science Foundation, The Signaling Transduction and Endocytosis Mechanism of PPAR Ligands’ Affect on the EGF Receptor (2005.1-2007.12), Endocytosis and Signaling Transduction of Epidermal Growth Factor Receptor (EGFR) (2005.1-2007.12)